首页 | 官方网站   微博 | 高级检索  
     


Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized,open‐label,prospective study (VISION)
Authors:L‐N Ji  C‐Y Pan  J‐M Lu  H Li  D‐L Zhu  Q Li  Q‐F Li  Y‐D Peng  H‐M Tian  C Yao  Z‐G Zhao  L Wang  B‐H Wang  for the VISION Study Group
Affiliation:1. Department of Endocrinology, Peking University People's Hospital, Beijing, China;2. Department of Endocrinology, Chinese PLA General Hospital, Beijing, China;3. Department of Endocrinology, Sir Run Run Shaw Hospital, Zhejiang University Medical College, Hangzhou, China;4. Department of Endocrinology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China;5. Department of Endocrinology and Metabolism, Second Affiliated Hospital of Harbin Medical University, Harbin, China;6. Department of Endocrinology, First Affiliated Hospital of Chongqing Medical University, Chongqing, China;7. Department of Endocrinology, Shanghai First People's Hospital, Shanghai, China;8. Department of Endocrinology, West China Hospital, Sichuan University, Chengdu, China;9. Department of Endocrinology, Peking University First Hospital, Beijing, China;10. Department of Endocrinology, Zhengzhou Yihe Hospital, Zhengzhou, China;11. Novartis Pharmaceuticals (China), Shanghai, China
Abstract:
Keywords:Chinese  glycated haemoglobin (HbA1c)  metformin  type 2 diabetes  vildagliptin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号